Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 8851-8900 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT07161232
The Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation
NA
Recruiting
72 participants
Started: Mar 28, 2025 · Completed: Mar 28, 2027
2 conditions
1 sponsor
1 location
NCT06632496
BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study
N/A
Recruiting
149 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06898203
Precision Imaging to Evaluate Kaposi Sarcoma
NA
Recruiting
100 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2029
1 condition
5 sponsors
2 locations
NCT06882746
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas
PHASE1
Recruiting
135 participants
Started: Mar 28, 2025 · Completed: May 12, 2027
3 conditions
1 sponsor
3 locations
NCT07152041
Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
PHASE3
Recruiting
150 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2030
2 conditions
1 sponsor
24 locations
NCT06867094
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
PHASE2
Recruiting
204 participants
Started: Mar 28, 2025 · Completed: May 11, 2028
1 condition
1 sponsor
83 locations
NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
PHASE2
Recruiting
240 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2027
1 condition
1 sponsor
56 locations
NCT06928545
MagDI U.S. Registry
N/A
Recruiting
106 participants
Started: Mar 28, 2025 · Completed: Apr 30, 2027
3 conditions
1 sponsor
3 locations
NCT06915012
Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
NA
Recruiting
102 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT07147660
Vision on the Road: Vision Rehabilitation for Driving After Stroke
NA
Recruiting
52 participants
Started: Mar 28, 2025 · Completed: Feb 29, 2028
3 conditions
2 sponsors
2 locations
NCT06800430
Graft Failure and Consequences of Coronary Artery Bypass Graft Surgery
N/A
Recruiting
70 participants
Started: Mar 28, 2025 · Completed: Aug 6, 2027
4 conditions
2 sponsors
1 location
NCT06840860
Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
N/A
Recruiting
1,000 participants
Started: Mar 28, 2025 · Completed: Feb 28, 2027
1 condition
9 sponsors
2 locations
NCT06827327
LC-Plasma for Preventing URTIs and Reducing Symptoms
PHASE3
Recruiting
650 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT06914375
Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health
NA
Recruiting
60 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06880653
Dose Response of Exercise for Arthritis Management
NA
Recruiting
285 participants
Started: Mar 28, 2025 · Completed: Apr 30, 2029
6 conditions
2 sponsors
1 location
NCT06913296
PTeye in Parathyroid Adenoma
N/A
Recruiting
50 participants
Started: Mar 28, 2025 · Completed: May 30, 2025
1 condition
1 sponsor
1 location
NCT06761287
Optimizing Patient Selection for Surgery Using Pathologic Analysis Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NA
Recruiting
20 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT06569667
Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids
NA
Recruiting
292 participants
Started: Mar 28, 2025 · Completed: Aug 31, 2026
1 condition
4 sponsors
1 location
NCT06421675
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
PHASE2
Recruiting
40 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2028
1 condition
2 sponsors
4 locations
NCT06408857
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
PHASE1
Recruiting
123 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2026
1 condition
1 sponsor
2 locations
NCT06938087
Assessment of Safety and Performances of a 3D Printed Prosthetic Foot: A Pilot Study
NA
Recruiting
3 participants
Started: Mar 28, 2025 · Completed: Apr 17, 2025
1 condition
3 sponsors
1 location
NCT06620809
The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders
PHASE1
Recruiting
69 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2027
1 condition
2 sponsors
1 location
NCT06895928
A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors
PHASE2
Recruiting
400 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06944106
A Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
PHASE2
Recruiting
30 participants
Started: Mar 28, 2025 · Completed: Mar 28, 2027
1 condition
1 sponsor
1 location
NCT06854653
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
PHASE2
Recruiting
115 participants
Started: Mar 28, 2025 · Completed: Jun 30, 2028
1 condition
1 sponsor
16 locations
NCT06900816
A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001
PHASE2
Recruiting
50 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06829537
Study of the Prevalence of Endogenous Hypercortisolism in Patients With Resistant Hypertension (MOMENTUM)
N/A
Recruiting
1,000 participants
Started: Mar 28, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
46 locations
NCT06830759
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
N/A
Recruiting
700 participants
Started: Mar 28, 2025 · Completed: Sep 30, 2031
2 conditions
2 sponsors
39 locations
NCT06573749
Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults
NA
Recruiting
96 participants
Started: Mar 28, 2025 · Completed: Jan 31, 2026
2 conditions
2 sponsors
1 location
NCT06718413
Myofascial Dysfunction in Post Stroke Shoulder Pain
PHASE2
Recruiting
68 participants
Started: Mar 28, 2025 · Completed: Aug 31, 2028
1 condition
2 sponsors
1 location
NCT06691893
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients
PHASE3
Recruiting
60 participants
Started: Mar 28, 2025 · Completed: Jul 15, 2027
2 conditions
2 sponsors
1 location
NCT06630884
Inflammatory Challenge and Fear
PHASE1
Recruiting
288 participants
Started: Mar 28, 2025 · Completed: Nov 30, 2028
1 condition
4 sponsors
1 location
NCT06869187
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
PHASE2
Recruiting
35 participants
Started: Mar 28, 2025 · Completed: Mar 13, 2026
1 condition
1 sponsor
11 locations
NCT06834230
Effect of Dotinurad in Hyperuricemia With Hypertension
PHASE4
Recruiting
360 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2030
2 conditions
1 sponsor
1 location
NCT06909357
Creation of an Infrastructure to Support Delivery of mHealth Interventions for Cancer Patients
NA
Recruiting
90 participants
Started: Mar 28, 2025 · Completed: Mar 31, 2026
1 condition
2 sponsors
3 locations
NCT06624371
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
PHASE1
Recruiting
18 participants
Started: Mar 28, 2025 · Completed: Oct 31, 2027
4 conditions
2 sponsors
2 locations
NCT06889389
Effects of Education and Exercise on Pain, Psychosocial Factors, and Upper Limb Function in Non-specific Neck Pain.
NA
Recruiting
81 participants
Started: Mar 28, 2025 · Completed: Jan 30, 2026
5 conditions
1 sponsor
1 location
NCT06750289
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
PHASE3
Recruiting
400 participants
Started: Mar 28, 2025 · Completed: Nov 2, 2027
1 condition
1 sponsor
131 locations
NCT06443606
Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
PHASE3
Recruiting
108 participants
Started: Mar 27, 2025 · Completed: Jun 1, 2029
2 conditions
1 sponsor
1 location
NCT06743269
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
NA
Recruiting
30 participants
Started: Mar 27, 2025 · Completed: Jan 31, 2027
3 conditions
1 sponsor
1 location
NCT06029491
The Pivotal Study of RapidPulseTM Aspiration System
NA
Recruiting
170 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
30 locations
NCT06971016
"Effectiveness of Mulligan Mobilization Technique and Proprioceptive Exercises Among Patients With Knee Osteoarthritis"
NA
Recruiting
60 participants
Started: Mar 27, 2025 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06897644
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
PHASE3
Recruiting
340 participants
Started: Mar 27, 2025 · Completed: Jan 1, 2030
1 condition
2 sponsors
28 locations
NCT06270303
Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects
NA
Recruiting
200 participants
Started: Mar 27, 2025 · Completed: Mar 1, 2037
2 conditions
7 sponsors
1 location
NCT06923241
Nutri-score Labelling in a UK Restaurant Setting: a Randomised Control Trial
NA
Recruiting
450 participants
Started: Mar 27, 2025 · Completed: Aug 31, 2025
3 conditions
3 sponsors
1 location
NCT06644781
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
PHASE3
Recruiting
510 participants
Started: Mar 27, 2025 · Completed: Nov 1, 2029
1 condition
2 sponsors
46 locations
NCT06647069
DR-0201 in Subjects With Autoimmune Diseases
PHASE1
Recruiting
36 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
12 conditions
1 sponsor
8 locations
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
PHASE3
Recruiting
700 participants
Started: Mar 27, 2025 · Completed: Feb 29, 2032
1 condition
2 sponsors
347 locations
NCT06618313
One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL
NA
Recruiting
8 participants
Started: Mar 27, 2025 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06744582
Estimating VO2 Max and Recovery
N/A
Recruiting
30 participants
Started: Mar 27, 2025 · Completed: Apr 30, 2026
1 condition
2 sponsors
2 locations
Previous
1
More pages
175
176
177
178
179
180
181
More pages
1333
Next